Skip to main content

Table 1 Dosimetric comparison between VMAT and IMRT plans: planned target volume and organs at risk

From: Peripheral dose measurements in cervical cancer radiotherapy: a comparison of volumetric modulated arc therapy and step-and-shoot IMRT techniques

  

VMAT

IMRT

p-value

PTV

    
 

D2% (Gy)

51.9 ± 0.5

52.2 ± 0.3

0.02

 

D98% (Gy)

47.4 ± 1.6

48.0 ± 0.3

0.36

 

V95% (%)

98.7 ± 0.8

98.7 ± 0.4

0.59

 

V105% (%)

0.5 ± 0.4

1.3 ± 1.1

0.22

 

D5% - D95% (Gy)

3.3 ± 1.1

3.0 ± 0.3

0.07

 

CI90

1.5 ± 0.3

1.7 ± 0.2

0.06

Rectum

    
 

Mean (Gy)

37.1 ± 1.5

38.1 ± 1.7

0.21

 

D2% (Gy)

49.5 ± 0.6

49.4 ± 0.9

0.60

 

V40Gy (%)

39.2 ± 5.1

40.7 ± 5.1

0.51

Bladder

    
 

Mean (Gy)

38.1 ± 1.4

38.8 ± 1.9

0.22

 

D2% (Gy)

50.4 ± 0.9

50.3 ± 0.5

0.77

 

V40Gy (%)

47.3 ± 4.0

46.6 ± 5.6

0.63

Small bowel

    
 

Mean (Gy)

28.8 ± 2.5

30.1 ± 1.4

0.03

 

D2% (Gy)

49.5 ± 0.8

49.9 ± 0.5

0.29

 

V40Gy (%)

20.3 ± 3.3

21.3 ± 3.5

0.41

Left femoral head

    
 

D2% (Gy)

39.8 ± 1.7

40.3 ± 4.1

0.13

 

V40Gy (%)

2.3 ± 1.4

2.9 ± 1.9

0.46

Right femoral head

    
 

D2% (Gy)

39.1 ± 3.5

39.2 ± 5.0

0.18

 

V40Gy (%)

2.5 ± 1.7

2.6 ± 1.9

0.60

  1. PTV: planning target volume; VMAT: volumetric modulated arc therapy; IMRT: intensity-modulated radiotherapy; D2%: dose received by 2% of the tissue; D98%: dose received by 98% of the tissue; V95%: the volume receiving at least 95% of the prescribed dose; V105%: the volume receiving at least 105% of the prescribed dose; D5% - D95%: difference between the dose covering 5% and 95% of the planning target volume; CI90%: conformity index, defined as the ratio between the volume receiving at least 90% of the prescribed dose and the planning target volume; V40Gy: volume receiving a dose of 40 Gy.